Drug Name Diflucan

Bioavailability is defined as the fraction of a given drug dose that reaches the circulation in unchanged form and becomes available for systemic distribution. The larger the presystemic elimination, the smaller is the bioavailability of an orally administered drug. Drugs are designed to exert a selective influence on vital processes in order to alleviate or eliminate symptoms of disease.
Zolpidem (an imidazopyridine) and zopiclone (a cyclopyrrolone) are hypnotics that, despite their different chemical structure, possess agonist activity at the benzodiazepine receptor (p. 226). Due to their narrower margin of safety (risk of misuse for suicide) and their potential to produce physical dependence, barbiturates are no longer or only rarely used as hypnotics.

 

The degree of fluctuation in plasma level over a given dosing interval can be reduced by use of a dosage form permitting slow (sustained) release (p. 10). The time required to reach steadystate accumulation during multiple constant dosing depends on the rate of elimination. As a rule of thumb, a plateau is reached after approximately three elimination half-lives (t1/2).
Substitution on the amino group reduces affinity for ?-receptors, but increases it for ?-receptors (exception: ?-agonist phenylephrine), with optimal affinity being seen after the introduction of only one isopropyl group. Increasing the bulk of the amino substituent favors affinity for ?2-receptors (e. g. , fenoterol, salbutamol).